Predicting regression of cervical intraepithelial neoplasia grade 2 in women under 25 years.
Sykes PH, Simcock BJ, Innes CR, Harker D, Williman JA, Whitehead M, van der Griend RA, Lawton BA, Hibma M, Fitzgerald P, Dudley NM, Petrich S, Eva L, Bergzoll C, Kathuria J, McPherson G, Tristram A, Faherty J, Hardie D, Robertson A, Robertson V, Pather S, Wrede CD, Gastrell F, Fentiman G, John M, White E, Parker C, Sadler L.
Sykes PH, et al. Among authors: john m.
Am J Obstet Gynecol. 2022 Feb;226(2):222.e1-222.e13. doi: 10.1016/j.ajog.2021.09.009. Epub 2021 Sep 14.
Am J Obstet Gynecol. 2022.
PMID: 34534506
BACKGROUND: A number of retrospective and prospective studies have documented substantial rates of regression in cervical intraepithelial neoplasia grade 2 lesions in young women. Initial observational management of cervical intraepithelial neoplasia grade 2 is increasingl …
BACKGROUND: A number of retrospective and prospective studies have documented substantial rates of regression in cervical intraepithelial ne …